VMQ StocksFor the value investor looking to harness academic research in
an actively managed portfolio
Bits and BipsNewsletter delivering insights on linking traditional finance, macro trends and cryptocurrency opportunities to help investors build stronger, more diversified portfolios.
All premium products come with free basic membership.
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company’s individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
Learn more about whether Ardent Health, Inc. or Guardian Pharmacy Services, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
As of Wednesday, October 21, Guardian Pharmacy Services, Inc.’s GRDN share price has dipped by
5.19%, which has investors questioning if this is right time to buy.
As of Monday, September 14, Guardian Pharmacy Services, Inc.’s GRDN share price has surged by
5.77%, which has investors questioning if this is right time to sell.
As of Tuesday, August 11, Guardian Pharmacy Services, Inc.’s GRDN share price has dipped by
5.79%, which has investors questioning if this is right time to buy.
As of Friday, August 07, Guardian Pharmacy Services, Inc.’s GRDN share price has surged by
14.82%, which has investors questioning if this is right time to sell.
Rosalio Madrigal
Financial Summary
Share Statistics
GRDN
Industry Median
Percentile (All Stocks)
Market Cap (Mil)
$2,525.5
$2,064.9
58%
Shares Out (Mil)
63.8
79.7
53%
Institutional Ownership
74.7%
85.9%
45%
Float (Mil)
22.4
58.8
30%
Beta
na
0.74
na
Avg Daily Volume (000s)
384
684
53%
Price Change (52-week)
39.9%
82.2%
82%
Growth
GRDN
Industry Median
Percentile (All Stocks)
Sales (5yr)
14.5%
10.4%
72%
Net Income (5yr)
19.8%
(1.1%)
73%
EPS (5yr)
na
1.2%
na
Dividends (5yr)
0.0%
0.0%
0%
Cash Flow (5yr)
na
(17.3%)
na
Estimates
Qtrly
Current Fiscal Year
Next Fiscal Year
# of Estimates
7
7
7
Current EPS
$0.314
$1.301
$1.434
Month Ago EPS
$0.314
$1.301
$1.434
# Rev Up
1
1
3
# Rev Down
0
0
0
Three Months Ago EPS
$0.306
$1.273
$1.383
Year/Year Chg
(8.5%)
67.2%
104.1%
Financials
GRDN
Industry Median
Percentile (All Stocks)
Sales (TTM) (Mil)
$1,463
$1,532
55%
Net Income (TTM) (Mil)
$66
$31
57%
EPS (TTM)
$1.046
$0.300
61%
Operating Cash Flow (TTM) (Mil)
$99
$168
52%
Net Cash Flow (TTM) (Mil)
$71
$2
74%
Long-Term Debt (Q1) (Mil)
$32
$417
35%
Enterprise Value (Q1) (Mil)
$2,811
$2,409
54%
Valuation
GRDN
Industry Median
Percentile (All Stocks)
P/B
10.28
2.94
92%
P/E
38.5
27.5
81%
Dividend Yield
0.0%
0.0%
0%
PEG (5yr hist)
na
1.1
na
Ratios
GRDN
Industry Median
Percentile (All Stocks)
Gross Margin
21.6%
27.2%
23%
Net Margin
4.5%
1.3%
45%
ROA
16.5%
2.2%
94%
ROE
31.7%
6.8%
88%
Liabilities to Assets
41.9%
61.5%
33%
F-Score
7
5
82%
Guardian Pharmacy Services, Inc. did not pass any screens on 11/5/2026.
Looking for access to this powerful feature? Take the first step in becoming an A+ Investor today.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors